phosphorylcholine has been researched along with allopurinol in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 3 (16.67) | 29.6817 |
2010's | 7 (38.89) | 24.3611 |
2020's | 7 (38.89) | 2.80 |
Authors | Studies |
---|---|
Carlo, WA; Cifuentes, J; Matalon, S; Myles, C; Nieves, B; Ruiz-Oronoz, J | 1 |
Gravino, AE; Manna, L; Neglia, G; Picillo, E; Reale, S; Vescio, F; Vitale, F | 1 |
Gravino, AE; Manna, L; Picillo, E; Reale, S; Vitale, F | 1 |
Bianciardi, P; Cañavate, C; Cruz, I; Miró, G; Mortarino, M; Oliva, G; Vischer, C | 1 |
Badino, P; Farca, AM; Ferroglio, E; Miniscalco, B; Monticelli, P; Odore, R; Trisciuoglio, A | 1 |
Campino, L; Henriques, S; Maia, C; Marques, M; Nunes, M; Rolão, N | 1 |
Cerrone, A; Corso, R; Galiero, G; Gravino, AE; Manna, L; Muzj, P | 1 |
Kritsepi-Konstantinou, M; Mylonakis, ME; Oikonomidis, IL; Papadimitriou, S; Psalla, D; Tangalidi, MK | 1 |
Cordeiro-da-Silva, A; Dantas-Torres, F; Miró, G; Travi, BL | 1 |
Checa, R; Fariñas, F; Fermín, ML; Flores, L; Fragío, C; Gálvez, R; Marino, V; Martínez-Nevado, E; Miró, G; Montoya, A; Rojo, C; Troyano, A | 1 |
Cerón, JJ; Checa, R; Daza González, MA; Fermín Rodríguez, M; Fragío Arnold, C; Martínez Subiela, S; Miró, G; Montoya, A; Portero Fuentes, M; Rupérez Noguer, C | 1 |
Almeida, ADBPF; Ayres, EDCBS; de Carvalho, MR; de Oliveira Martins, DT; de Oliveira, RG; Dias, ÁFLR; Maruyama, FH; Mendonça, AJ; Sousa, VRF; Teixeira, ALS | 1 |
Alunda, JM; Cuquerella, M; Fontán-Matilla, E; Olías-Molero, AI | 1 |
Cardoso, L; Leal, RO; Monteiro, M; Pereira da Fonseca, I; Prata, S | 1 |
Alcover, MM; Fernández, A; Fisa, R; Giner, J; Riera, C; Verde, M; Villanueva-Saz, S; Yzuel, A | 1 |
Campos, MP; Figueiredo, FB; Gonçalves, AS; Gonçalves, G; Medeiros, LCS | 1 |
Almeida, ADBPF; Ayres, EDCBS; Barbosa, MEC; Dias, ÁFLR; Dutra, V; Macedo, LFDC; Monteiro, BRG; Nakazato, L; Pazzini, SS; Silva, EBD; Sousa, VRF | 1 |
Barbiéri, CL; da Silva, DAM; de Santana, FR; Katz, S; Oliveira, KC; Orikaza, CM | 1 |
1 review(s) available for phosphorylcholine and allopurinol
Article | Year |
---|---|
Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Disease Reservoirs; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Molecular Diagnostic Techniques; Organometallic Compounds; Phosphorylcholine; Point-of-Care Systems; Serologic Tests | 2018 |
2 trial(s) available for phosphorylcholine and allopurinol
Article | Year |
---|---|
Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis.
Topics: Allopurinol; Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2009 |
Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Retrospective Studies | 2015 |
15 other study(ies) available for phosphorylcholine and allopurinol
Article | Year |
---|---|
Interaction of surfactant mixtures with reactive oxygen and nitrogen species.
Topics: Animals; Antioxidants; Biological Products; Drug Combinations; Fatty Alcohols; Formaldehyde; Free Radical Scavengers; Free Radicals; Hydrogen Peroxide; In Vitro Techniques; Lung; Nitrates; Nitrogen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Rabbits; Reactive Oxygen Species; Surface Tension; Xanthine Oxidase | 1995 |
Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Disease Models, Animal; Disease Reservoirs; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Phosphorylcholine; Recurrence; Treatment Outcome; Zoonoses | 2009 |
Interferon-gamma (INF-gamma), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Biomarkers; DNA, Protozoan; Dog Diseases; Dogs; Interferon-gamma; Interleukin-4; Leishmania infantum; Leishmaniasis, Visceral; Phosphorylcholine | 2008 |
Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Synergism; Fluoroquinolones; Leishmania infantum; Leishmaniasis, Visceral; Phosphorylcholine | 2012 |
In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Deoxycholic Acid; Disease Reservoirs; Dog Diseases; Dogs; Drug Combinations; Humans; Immunocompetence; Immunocompromised Host; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine | 2013 |
Nodular granulomatous glossitis as the sole clinical sign in canine leishmaniosis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Fluorescent Antibody Technique, Indirect; Glossitis; Immunohistochemistry; Leishmania infantum; Leishmaniasis, Visceral; Male; Phosphorylcholine; Tongue | 2016 |
First report of Leishmania infantum infection in the endangered orangutan (Pongo pygmaeus pygmaeus) in Madrid, Spain.
Topics: Allopurinol; Animals; Diagnosis, Differential; Disease Outbreaks; Endangered Species; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Phosphorylcholine; Pongo pygmaeus; Psychodidae; Spain | 2018 |
Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis.
Topics: Acute-Phase Proteins; Allopurinol; Animals; Antiprotozoal Agents; Aryldialkylphosphatase; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Meglumine Antimoniate; Phosphorylcholine | 2019 |
Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Cytokines; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmaniasis, Visceral; Male; Phosphorylcholine | 2020 |
Scientometric analysis of chemotherapy of canine leishmaniasis (2000-2020).
Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Combinations; Drug Therapy; Humans; Leishmania infantum; Leishmaniasis; Leishmaniasis, Visceral; Phosphorylcholine; Publications | 2021 |
Diagnosis and clinical management of canine leishmaniosis by general veterinary practitioners: a questionnaire-based survey in Portugal.
Topics: Adult; Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Humans; Knowledge; Leishmania infantum; Leishmaniasis; Male; Middle Aged; Phosphorylcholine; Portugal; Practice Guidelines as Topic; Surveys and Questionnaires; Veterinarians | 2021 |
Clinical leishmaniosis in a domestic ferret (Mustela putorius furo) treated with miltefosine plus allopurinol: Serological and clinical follow-up.
Topics: Allopurinol; Animals; Ferrets; Follow-Up Studies; Leishmania infantum; Phosphorylcholine | 2021 |
Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Female; Leishmania infantum; Leishmaniasis, Visceral; Meglumine Antimoniate; Phosphorylcholine | 2021 |
Clinical and parasitological impact of short-term treatment using miltefosine and allopurinol monotherapy or combination therapy in canine visceral leishmaniasis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Phosphorylcholine | 2022 |
A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Body Weight; Cricetinae; Leishmania infantum; Leishmaniasis, Visceral; Mesocricetus; Phosphorylcholine | 2022 |